Sequifenadine

Sequifenadine is a H1-antihistamine. Sequifenadine has the potential for the research of inflammatory eye disease with allergic symptoms[1][2].

Product Specifications

CAS Number

[57734-69-7]

UNSPSC

12352005

Hazard Statement

H302-H315-H319-H335

Target

Histamine Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/sequifenadine.html

Solubility

10 mM in DMSO

Smiles

CC1=CC=CC=C1C(C2=CC=CC=C2C)(C3CN4CCC3CC4)O

Molecular Formula

C22H27NO

Molecular Weight

321.46

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

References & Citations

[1]Bukovskis, Maris, et al. H1-antihistamines suppress wheal-and-flare reaction and skin blood perfusion measured by laser doppler flowmetry: randomized, double-blind, placebo-controlled, crossover design study.|[2]Ophthalmic drops for treatment of inflammatory eye disease with allergic symptoms. Patent RU2156128C1.